⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MNOV News
Medicinova, Inc.
MediciNova Announces Completion of Patient Enrollment in MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
globenewswire.com
MNOV
MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication
globenewswire.com
MNOV
MediciNova to Present at the LD Micro Main Event XIX Investor Conference
globenewswire.com
MNOV